Medical Access

Business

UFC Inks Multi-Year Deal with Good Greek, Expanding Year-Round Sponsorship Footprint

TKO Group Holdings' UFC has secured a new, multi-year marketing partnership with Good Greek Moving & Storage. The agreement will feature brand integration across UFC Fight Nights, Dana White's Contender Series, and athlete ambassador campaigns, signaling a continued push to monetize its combat sports audience beyond traditional media rights.

Feb 2, 2026

Business

Cash ISA Rates in Focus: Savers Navigate Tax-Free Options Amid Shifting Allowances

With the annual ISA allowance set to shrink for many in 2027, finding the best tax-free cash savings rate is more crucial than ever. We break down the top deals and what the changes mean for your money.

Feb 2, 2026

Business

Beyond the Penny Stock Stigma: Three European Small-Caps with Solid Footing

Amidst a cautiously optimistic economic backdrop in Europe, we examine three publicly traded companies with market capitalizations exceeding €30 million that combine the growth potential of small-caps with notable financial resilience.

Feb 2, 2026

Business

InflaRx's Cash Runway Narrows: Can the Biotech Steer Through Financial Headwinds?

With a cash reserve that could last just over a year at its current burn rate, InflaRx faces a critical period to prove its clinical pipeline's value. While management has reined in spending, the company's financial strategy is now under the microscope.

Feb 2, 2026

Business

Cash-Rich Companies: One Stock Poised for Growth, Two Facing Headwinds

While a strong cash position often signals financial health, it can also mask underlying business challenges. We analyze three cash-heavy stocks, highlighting one standout opportunity and two where caution is warranted.

Feb 2, 2026

Business

Beyond the Bottom Line: One Profitable Stock to Watch, Two to Question

Profitability alone doesn't guarantee a winning investment. We examine three companies with strong margins, highlighting one that leverages its financial strength effectively and two where underlying challenges warrant a closer look.

Feb 2, 2026

US-Africa Trade Pact AGOA Granted Stopgap Reprieve, Long-Term Future Remains Uncertain

A last-minute, short-term extension of the cornerstone US-Africa trade program AGOA has been passed, averting immediate expiration but leaving businesses and governments on both continents anxious about the partnership's long-term trajectory.

Feb 2, 2026

World

Lammy's £100m Legal Sector Tax Plan Sparks Fears of Widespread Job Losses

Justice Secretary David Lammy's proposal to redirect interest from law firms' client accounts to fund the justice system could jeopardize up to 6,500 jobs, according to industry analysis, raising alarms about the financial stability of the sector.

Feb 2, 2026

Business

Value Traps: Three Seemingly Cheap Stocks Analysts Are Avoiding

While the value investing strategy has minted legends like Buffett, true bargains are rare. We examine three stocks with low P/E ratios that, despite their apparent discount, face significant headwinds that keep them off many buy lists.

Feb 2, 2026

World

Latin America's Balancing Act: Navigating the Surge of Chinese Imports

As Chinese exports, from electric vehicles to e-commerce parcels, flood Latin American markets, nations across the region are grappling with the dual pressures of protecting domestic industries and maintaining vital economic ties with Beijing.

Feb 2, 2026

Business

Beyond the Benchmark: Two S&P 500 Stocks with Momentum and One Facing Headwinds

The S&P 500 is home to market leaders, but not all its constituents are created equal. We examine one company navigating challenges and two others positioned for potential growth, providing context on their valuations and market positions.

Feb 2, 2026

Business

Bargain Hunting or Value Trap? One Stock Primed for a Rebound, Two Others Raise Red Flags

As several prominent stocks test 52-week lows, investors face a critical choice: identify oversold opportunities or steer clear of troubled names. We analyze one company showing signs of a turnaround and two where caution may be warranted.

Feb 2, 2026

Business

Wall Street's Uncomfortable Truth: Three High-Profile Stocks Analysts Are Quietly Souring On

In a rare break from Wall Street's typically optimistic consensus, a handful of prominent stocks are receiving bearish price targets that signal deep-seated concerns. We examine the challenges facing Deckers, MSC Industrial, and Guardant Health, and why investors might want to look elsewhere.

Feb 2, 2026

Business

Saks Global Severs Ties with Amazon Amid Bankruptcy Restructuring

The luxury retailer is moving to terminate its 'Saks on Amazon' partnership as part of its Chapter 11 proceedings, aiming to refocus on core luxury operations while navigating disputes over financial commitments and brand concerns.

Feb 2, 2026

Business

Hims & Hers Health Stock Plunges 57%: Is the Telehealth Pioneer Now a Value Play?

Shares of the direct-to-consumer telehealth company Hims & Hers have been halved over the past six months, trading near $27. Investors are now weighing whether the steep sell-off presents a buying opportunity or signals deeper troubles ahead.

Feb 2, 2026

Business

Healthcare Tech Stocks Navigate Turbulent Q3: Omnicell Surges While Peers Stumble

The third-quarter earnings season revealed a stark divergence in performance among leading healthcare technology providers. While Omnicell impressed with strong results and a soaring stock, peers like Evolent Health and Astrana Health faced significant market headwinds despite revenue beats.

Feb 2, 2026

Business

Binance's Resilience Tested: Trust in the World's Largest Exchange Faces Scrutiny After Historic 2025 Market Crash

In the aftermath of the devastating '10/10' market crash of 2025, Binance finds its dominance and trust metrics under a microscope. While the exchange compensated users and maintains its user base, questions about systemic risk and centralization linger, shaping the post-crash narrative.

Feb 2, 2026

Business

Three Global Stocks Trading at a Discount: Undervalued Picks for February 2026

Amid a market environment of stable rates and mixed sentiment, we highlight three companies—spanning biotech, gaming, and tech hardware—whose current share prices appear significantly below their estimated intrinsic value based on cash flow projections.

Feb 2, 2026

Business

AstraZeneca Shifts Gears: Full NYSE Listing Marks Strategic Pivot to US Market

The UK pharmaceutical giant AstraZeneca begins trading ordinary shares on the New York Stock Exchange today, a significant upgrade from its previous Nasdaq ADR listing. This move underscores the company's strategic rebalancing towards the United States, its largest market, and raises questions about the long-term relevance of its London listing.

Feb 2, 2026

Business

Beyond the Consensus: One Overlooked Stock Opportunity and Two High-Risk Bets

In a market where Wall Street analysts often shy away from bearish calls, stark price targets on certain stocks raise red flags. We spotlight one contrarian pick and two companies facing significant headwinds.

Feb 2, 2026